Evidence map›Paper›PMID 38361868›Full record

ArticleJournal of family medicine and primary care2023

COVID-19-induced hair shedding and related risk factors: A Saudi perspective.

Abrar E Bukhari, Dalal A AlDosari, Manal A AlDosari, Reema F Muqrin, Othillah M Moazin, Malak M Almutlq, Saad M Altalhab, Ruaa S Alharithy, Abdullah I Alkhalifah

Open access · goldAbstract read
In one paragraph

Article in Journal of family medicine and primary care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Abrar E BukhariDepartment of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Dalal A AlDosariDepartment of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Manal A AlDosariDepartment of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Reema F MuqrinDepartment of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Othillah M MoazinDepartment of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Malak M AlmutlqDepartment of Dermatology, King Fahad Medical City, Riyadh, Saudi Arabia.
Saad M AltalhabDepartment of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Ruaa S AlharithyDepartment of Dermatology, Princess Nourah Bint Abdul Rahman University, Security Forces Hospital, Riyadh, Saudi Arabia.
Abdullah I AlkhalifahDepartment of Dermatology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Imam Mohammad ibn Saud Islamic University · SAKing Fahd Medical City · SARiyadh Armed Forces Hospital · SASecurity Forces Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Many cases of telogen effluvium (TE), acute hair shedding, following coronavirus disease 2019 (COVID-19) were reported during the pandemic. Methodology: We conducted a cross-sectional study to assess the relationship between COVID-19 and TE in Saudi Arabia. Self-administered online questionnaires were distributed online between March and September 2022 in Saudi Arabia. A multivariate logistic regression model was used to determine risk factors associated with TE post-COVID-19 (significance at Results: Of the 703 responders, 392 were included in the study. 59.70% ( Conclusion: Healthcare providers and physicians should be aware of the relationship between TE and COVID-19, to easily recognize, treat, and improve their patients' outcomes).

Indexed as

COVID-19hair lossSARS-CoV-2telogen effluvium

Identifiers

PMID38361868
PMCPMC10866268
OpenAlexW4389879799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.